Insights

NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right of consumers and patients to purchase regulated products. The central question was whether legal Cannabis could exist at all. Operators, ...

LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. The global Cannabis concentrate market, valued at roughly $1.6 billion in 2025, is projected to reach $9 billion by 2036 ...

RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in the unusual position of allowing adult possession and home cultivation while continuing to block a legal adult-use retail market. For ...

DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s Behavioral Health Administration. The bill authorizes up to five research sites to study the safety and effectiveness of ibogaine for ...

WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more important issue is whether state medical Cannabis licenses, medical designations, and documented medical operations will be enough to qualify under ...

NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among adults aged 60 and older: many are turning to Cannabis products because they are dissatisfied with conventional medications, concerned about ...

NEW YORK-Cannabis is entering a new phase, and this one is about much more than consumption. For decades, Cannabis was trapped in prohibition and treated mainly as a legal problem. Then came commercialization, when Cannabis became a consumer product defined by branding, potency, strain names, and the promise of a certain experience. Both phases mattered, ...

NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two non-intoxicating Cannabis compounds, CBD and CBG, significantly reduced liver fat and improved metabolic health in experimental models of fatty liver ...

NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The deeper opportunity is understanding how Cannabis interacts with one of the body’s most important regulatory networks: the endocannabinoid system. The ...

NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune response, inflammatory signaling, pain, metabolism, and recovery. That matters because chronic inflammation is not just a symptom of disease. It ...

NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of calories or weight, metabolism is fundamentally a cellular process governed by hormonal signaling, mitochondrial function, and nutrient utilization. When it ...

NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal Cannabis trade has produced to date. The report draws on billions of dollars in actual transactions and covers more than ...

LOS ANGELES- The cannabis industry is entering a new phase. The first era—Cannabis 1.0—was defined by prohibition and the fight for legalization. Cannabis 2.0 followed, driven by commercialization: brands, retail expansion, and the rapid scaling of products into consumer markets. What comes next is fundamentally different. Cannabis 3.0 is not about access or scale. It ...

WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen to date. First reported by Psychedelic Alpha, the order directs federal agencies to reduce regulatory barriers, deploy funding, and compress ...

Virginia’s Cannabis market has been “legal” on paper for years. In practice, it’s been stuck in neutral—possession allowed, but no regulated retail system to match it. That may finally be shifting. The latest move out of Richmond Abigail Spanberger is stepping in with a set of proposed amendments that reshape how—and when—Virginia’s long-delayed Cannabis sales ...